Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

111, a Shanghai Online-Offline Pharmacy, Raises $100 Million in US IPO

publication date: Sep 13, 2018

111, Inc., a new retail online/offline pharmacy, has completed a US IPO on the NASDAQ exchange, raising $100 million at a $1.1 billion market capitalization. Initially, 111 was seeking to raise as much as $150 million, but market considerations led the underwriters to lower the size of the offering. Founded in 2010, 111 includes 1 Drugstore, an online pharmacy that it claims is China's largest; 1 Clinic, which provides online consultations; and 1 Drug Mall, a B2B cloud-computing/big data/supply chain for pharmacies to manage inventory. More details....

Stock Symbol: (NSDQ: YI)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.